16-1220213-C-T

Variant summary

Our verdict is Benign. The variant received -7 ACMG points: 0P and 7B. BP4_ModerateBP6BS2

The NM_021098.3(CACNA1H):​c.6281C>T​(p.Ser2094Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000331 in 1,570,624 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. S2094W) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.000046 ( 0 hom., cov: 35)
Exomes 𝑓: 0.000032 ( 0 hom. )

Consequence

CACNA1H
NM_021098.3 missense

Scores

1
3
15

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:1

Conservation

PhyloP100: 0.734

Publications

2 publications found
Variant links:
Genes affected
CACNA1H (HGNC:1395): (calcium voltage-gated channel subunit alpha1 H) This gene encodes a T-type member of the alpha-1 subunit family, a protein in the voltage-dependent calcium channel complex. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization and consist of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. The alpha-1 subunit has 24 transmembrane segments and forms the pore through which ions pass into the cell. There are multiple isoforms of each of the proteins in the complex, either encoded by different genes or the result of alternative splicing of transcripts. Alternate transcriptional splice variants, encoding different isoforms, have been characterized for the gene described here. Studies suggest certain mutations in this gene lead to childhood absence epilepsy (CAE). [provided by RefSeq, Jul 2008]
CACNA1H Gene-Disease associations (from GenCC):
  • hyperaldosteronism, familial, type IV
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • childhood absence epilepsy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • epilepsy, childhood absence, susceptibility to, 6
    Inheritance: AD Classification: LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -7 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.1724599).
BP6
Variant 16-1220213-C-T is Benign according to our data. Variant chr16-1220213-C-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 1041003.
BS2
High AC in GnomAd4 at 7 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CACNA1HNM_021098.3 linkc.6281C>T p.Ser2094Leu missense_variant Exon 35 of 35 ENST00000348261.11 NP_066921.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CACNA1HENST00000348261.11 linkc.6281C>T p.Ser2094Leu missense_variant Exon 35 of 35 1 NM_021098.3 ENSP00000334198.7
CACNA1HENST00000569107.6 linkc.6296C>T p.Ser2099Leu missense_variant Exon 34 of 34 1 ENSP00000454990.2
CACNA1HENST00000711493.1 linkc.6266C>T p.Ser2089Leu missense_variant Exon 34 of 34 ENSP00000518778.1
CACNA1HENST00000565831.7 linkc.6263C>T p.Ser2088Leu missense_variant Exon 34 of 34 1 ENSP00000455840.1
CACNA1HENST00000711450.1 linkc.6263C>T p.Ser2088Leu missense_variant Exon 35 of 35 ENSP00000518762.1
CACNA1HENST00000564231.6 linkc.6248C>T p.Ser2083Leu missense_variant Exon 35 of 35 1 ENSP00000457555.2
CACNA1HENST00000638323.1 linkc.6242C>T p.Ser2081Leu missense_variant Exon 35 of 35 5 ENSP00000492267.1
CACNA1HENST00000562079.6 linkc.6230C>T p.Ser2077Leu missense_variant Exon 34 of 34 1 ENSP00000454581.2
CACNA1HENST00000711438.1 linkc.6224C>T p.Ser2075Leu missense_variant Exon 34 of 34 ENSP00000518754.1
CACNA1HENST00000711482.1 linkc.6174C>T p.Leu2058Leu synonymous_variant Exon 36 of 36 ENSP00000518771.1
CACNA1HENST00000711485.1 linkc.6123C>T p.Leu2041Leu synonymous_variant Exon 35 of 35 ENSP00000518774.1
CACNA1HENST00000711455.1 linkc.6096C>T p.Leu2032Leu synonymous_variant Exon 36 of 36 ENSP00000518768.1
CACNA1HENST00000637236.3 linkn.*2200C>T non_coding_transcript_exon_variant Exon 34 of 34 5 ENSP00000492650.2
CACNA1HENST00000639478.1 linkn.*1329C>T non_coding_transcript_exon_variant Exon 35 of 35 5 ENSP00000491945.1
CACNA1HENST00000640028.1 linkn.*4099C>T non_coding_transcript_exon_variant Exon 35 of 35 5 ENSP00000491488.1
CACNA1HENST00000711442.1 linkn.*5725C>T non_coding_transcript_exon_variant Exon 33 of 34 ENSP00000518758.1
CACNA1HENST00000711448.1 linkn.*1222C>T non_coding_transcript_exon_variant Exon 36 of 36 ENSP00000518760.1
CACNA1HENST00000711449.1 linkn.*1140C>T non_coding_transcript_exon_variant Exon 35 of 35 ENSP00000518761.1
CACNA1HENST00000711451.1 linkn.*1860C>T non_coding_transcript_exon_variant Exon 36 of 36 ENSP00000518763.1
CACNA1HENST00000711452.1 linkn.*948C>T non_coding_transcript_exon_variant Exon 36 of 36 ENSP00000518764.1
CACNA1HENST00000711453.1 linkn.*915C>T non_coding_transcript_exon_variant Exon 36 of 36 ENSP00000518765.1
CACNA1HENST00000711484.1 linkn.*195C>T non_coding_transcript_exon_variant Exon 34 of 35 ENSP00000518773.1
CACNA1HENST00000711486.1 linkn.6281C>T non_coding_transcript_exon_variant Exon 35 of 37 ENSP00000518775.1
CACNA1HENST00000711487.1 linkn.6248C>T non_coding_transcript_exon_variant Exon 35 of 36 ENSP00000518776.1
CACNA1HENST00000711488.1 linkn.*1397C>T non_coding_transcript_exon_variant Exon 35 of 35 ENSP00000518777.1
CACNA1HENST00000711483.1 linkc.*195C>T 3_prime_UTR_variant Exon 35 of 35 ENSP00000518772.1
CACNA1HENST00000711456.1 linkc.*195C>T 3_prime_UTR_variant Exon 34 of 34 ENSP00000518769.1
CACNA1HENST00000637236.3 linkn.*2200C>T 3_prime_UTR_variant Exon 34 of 34 5 ENSP00000492650.2
CACNA1HENST00000639478.1 linkn.*1329C>T 3_prime_UTR_variant Exon 35 of 35 5 ENSP00000491945.1
CACNA1HENST00000640028.1 linkn.*4099C>T 3_prime_UTR_variant Exon 35 of 35 5 ENSP00000491488.1
CACNA1HENST00000711442.1 linkn.*5725C>T 3_prime_UTR_variant Exon 33 of 34 ENSP00000518758.1
CACNA1HENST00000711448.1 linkn.*1222C>T 3_prime_UTR_variant Exon 36 of 36 ENSP00000518760.1
CACNA1HENST00000711449.1 linkn.*1140C>T 3_prime_UTR_variant Exon 35 of 35 ENSP00000518761.1
CACNA1HENST00000711451.1 linkn.*1860C>T 3_prime_UTR_variant Exon 36 of 36 ENSP00000518763.1
CACNA1HENST00000711452.1 linkn.*948C>T 3_prime_UTR_variant Exon 36 of 36 ENSP00000518764.1
CACNA1HENST00000711453.1 linkn.*915C>T 3_prime_UTR_variant Exon 36 of 36 ENSP00000518765.1
CACNA1HENST00000711484.1 linkn.*195C>T 3_prime_UTR_variant Exon 34 of 35 ENSP00000518773.1
CACNA1HENST00000711488.1 linkn.*1397C>T 3_prime_UTR_variant Exon 35 of 35 ENSP00000518777.1
CACNA1HENST00000621827.2 linkn.6121+160C>T intron_variant Intron 35 of 36 6 ENSP00000518766.1

Frequencies

GnomAD3 genomes
AF:
0.0000460
AC:
7
AN:
152190
Hom.:
0
Cov.:
35
show subpopulations
Gnomad AFR
AF:
0.0000724
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000588
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000302
AC:
6
AN:
198706
AF XY:
0.0000179
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.000208
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000327
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000317
AC:
45
AN:
1418434
Hom.:
0
Cov.:
73
AF XY:
0.0000355
AC XY:
25
AN XY:
703762
show subpopulations
African (AFR)
AF:
0.0000328
AC:
1
AN:
30442
American (AMR)
AF:
0.00
AC:
0
AN:
40720
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
24326
East Asian (EAS)
AF:
0.000268
AC:
10
AN:
37336
South Asian (SAS)
AF:
0.0000246
AC:
2
AN:
81390
European-Finnish (FIN)
AF:
0.0000673
AC:
3
AN:
44578
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5630
European-Non Finnish (NFE)
AF:
0.0000256
AC:
28
AN:
1095290
Other (OTH)
AF:
0.0000170
AC:
1
AN:
58722
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
3
7
10
14
17
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000460
AC:
7
AN:
152190
Hom.:
0
Cov.:
35
AF XY:
0.0000807
AC XY:
6
AN XY:
74346
show subpopulations
African (AFR)
AF:
0.0000724
AC:
3
AN:
41456
American (AMR)
AF:
0.00
AC:
0
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5178
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4838
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10626
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.0000588
AC:
4
AN:
68012
Other (OTH)
AF:
0.00
AC:
0
AN:
2092
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.489
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000108
Hom.:
0
Bravo
AF:
0.0000264
ExAC
AF:
0.0000341
AC:
4
Asia WGS
AF:
0.000289
AC:
1
AN:
3478

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:2Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Epilepsy, childhood absence, susceptibility to, 6;C4310756:Hyperaldosteronism, familial, type IV Uncertain:1
Feb 14, 2024
Fulgent Genetics, Fulgent Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Inborn genetic diseases Uncertain:1
Apr 07, 2023
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.6281C>T (p.S2094L) alteration is located in exon 35 (coding exon 34) of the CACNA1H gene. This alteration results from a C to T substitution at nucleotide position 6281, causing the serine (S) at amino acid position 2094 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Idiopathic generalized epilepsy;C4310756:Hyperaldosteronism, familial, type IV Benign:1
Jun 03, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.077
BayesDel_addAF
Benign
-0.14
T
BayesDel_noAF
Benign
-0.14
CADD
Benign
18
DANN
Uncertain
0.99
DEOGEN2
Benign
0.20
T;.;.;.
Eigen
Benign
-0.69
Eigen_PC
Benign
-0.68
FATHMM_MKL
Benign
0.28
N
LIST_S2
Benign
0.83
T;T;T;.
M_CAP
Pathogenic
0.40
D
MetaRNN
Benign
0.17
T;T;T;T
MetaSVM
Uncertain
-0.028
T
MutationAssessor
Benign
1.5
L;.;.;.
PhyloP100
0.73
PrimateAI
Benign
0.41
T
PROVEAN
Benign
-2.0
N;.;N;N
REVEL
Benign
0.27
Sift
Uncertain
0.012
D;.;D;D
Sift4G
Benign
0.27
T;.;T;T
Polyphen
0.043
B;.;B;B
Vest4
0.082
MutPred
0.20
Loss of glycosylation at S2094 (P = 0.0081);.;.;.;
MVP
0.64
ClinPred
0.11
T
GERP RS
4.3
Varity_R
0.31
gMVP
0.16
Mutation Taster
=80/20
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs371550084; hg19: chr16-1270213; API